Antarka
The Future of Skincare Begins at the Source
Montevideo, Uruguay · Founded 2023 · $600K raised
- Headquarters
- Montevideo
- Employees
- 1–10
- Founded
- 2023
- Website
- antarka.bio
- Total Funding
- $600K
- Last Round
- $600K SeedJan 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Antarka is a Uruguayan biotechnology startup developing skin DNA-repair enzymes for cosmetic and skincare applications. Its flagship active, ANKros-CPD, is a CPD-photolyase enzyme sourced from UV-resistant Antarctic extremophile bacteria that recognizes and repairs UV-induced DNA damage in skin at the molecular level. Spun out of research at Uruguay's Universidad de la República, Antarka supplies the skin-permeable active ingredient to cosmetic brands for formulation into longevity and sun-care products.
Summary
Antarka is a Biotech company based in Montevideo, Uruguay, founded in 2023. It has raised $600K in total across 1 round, most recently a $600K Seed round in Jan 2023. Investors include SOSV and IndieBio.
Funding History
2023 (est.)
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/antarka"><img src="https://indexed.vc/api/badge/company/antarka" alt="Antarka on Indexed.vc" width="260" height="76" /></a>